Olmesartan Medoxomil contains not less than 97.5% and not more than 102.0% of Olmesartan Medoxomil Calculated on the anhydrous basis.

共有 1 個藥物證書使用此成份

奧美沙坦酯
Olmesartan Medoxomil

• 申請商: 西海生技股份有限公司
• 適應症: 高血壓用藥
• 發證日期: 2020-10-08